CD3+CD4-CD8-double negative T cells (DNTs) have emerged as functional immune cells in the field of antitumor therapy because they induce high cytotoxicity in multiple tumor cells in a nonspecific manner without causing graft-versus-host disease (GVHD) 36, 37. This evidence concerns the gene CD4 and graft versus host disease.